stockrowDoximity, Inc.
DOCS Healthcare Health Information Services
Doximity, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $644.9 million, up 13.1% from fiscal 2025.
- Revenue
- +3.57%
- EPS
- −42.4%
- Free cash flow
- +1.87%
Quarter to September 2026, against a year earlier
Follow DOCS
Alert me
Doximity, Inc. (DOCS) Shares outstanding
Doximity, Inc.'s shares outstanding at the end of fiscal 2026 was $199.0M, unchanged from fiscal 2025. At the end of the quarter to 30 September 2026 it was $187.8M. Over the past ten years it has ranged from $75.7M (fiscal 2019) to $213.4M (fiscal 2023); the current reading is higher than 63% of that period. Doximity, Inc. ranks 4th of 43 Health Information Services companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2026 | $199.0M | (1.07%) |
| FY2025 | $201.2M | (2.20%) |
| FY2024 | $205.7M | (3.60%) |
| FY2023 | $213.4M | 11.73% |
| FY2022 | $191.0M | 100.79% |
| FY2021 | $95.1M | 16.43% |
| FY2020 | $81.7M | 8.00% |
| FY2019 | $75.7M | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $187.8M | (1.76%) |
| Jun 2026 | $191.2M | (3.96%) |
| Mar 2026 | $199.0M | (0.09%) |
| Dec 2025 | $199.2M | (0.76%) |
| 23 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | $220.2M |
| WAY Waystar Holding Corp. compare | $195.9M |
| DOCS Doximity, Inc. | $187.8M |
| TEM Tempus AI, Inc. compare | $181.3M |
| PRVA Privia Health Group, Inc. compare | $132.7M |
| HTFL Heartflow, Inc. compare | $86.4M |
| HQY HealthEquity, Inc. compare | $84.0M |
| HNGE Hinge Health Inc. compare | $83.4M |
| SDGR Schrodinger, Inc. compare | $74.9M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on DOCS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement